• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » MediQual Systems sold to Quantros

MediQual Systems sold to Quantros

November 6, 2009 By MassDevice staff

MediQual Systems Inc., once a Cardinal Health data-mining subsidiary based in Marlborough, Mass., was sold to Quantros Inc.

The deal was announced Thursday by Milipas, Calif.-based Quantros, which said it plans to open an East Coast office in the existing MediQual facilities in Marlborough.

MediQual and Quantros both competed with several companies in the clinical- and decision-support business, including Quadramed Corp. and Eclipsys Corp., and specialty units of McKesson Corp., Health Management Systems and Siemen Medical Solutions.

MediQual split from Cardinal Health in September as part of the spin-off of Cardinal’s medical device and service businesses. The spinout company now operates as Carefusion, which Thursday reported $933 million in revenues during the three months ended Sept. 30.

Cardinal Health acquired MediQual 12 years ago for $35 million. Terms of the current sale were not disclosed.

Privately held Quantros manages and analyzes data for healthcare providers with an emphasis on improving patient safety. MediQual likewise frequently focused on safety concerns and three years ago was one of the primary investigators in a study of bloodstream infections acquired by patients during hospital stays.

The study’s conclusions were critical of many hospital procedures and were supported with information from MediQual’s extensive patient database.

“It comes free with the territory,” wrote vice president of clinical affairs Richard Johannes.

MediQual currently has about 120 employees. Annual sales for the firm were not immediately available.

Quantros officials said they expect to add more employees at Mediqual over the next 12 months.

“Quantros already has an expansive client footprint on the East Coast, beyond those healthcare providers using MediQual solutions,” said Randy Everett, head of operations at Quantros, in prepared remarks. “This new facility will add jobs to the greater Boston area and provide expanded opportunities to better serve the combined Quantros and MediQual client base.”

Quantros last year also acquired Medcast Health Analytics, a Cypress, Texas-based firm providing web-based financial analysis to hospitals and provider networks.

Filed Under: Business/Financial News, Software / IT

More recent news

  • Tandem continues to deliver more options, benefits for those with diabetes
  • Breaking: Sequel to launch twiist automated insulin delivery system next month
  • Dexcom shares U.S. report on CGM benefits for type 2 diabetes
  • Data backs Medtronic MiniMed 780G for type 2, children as company seeks expanded indications
  • Endogenex data supports type 2 diabetes procedure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy